Oral administration of L-arginine decreases necrosis of the epigastric skin flap in the rat

Annals of Plastic Surgery

Volumn 53, Issue 1, 2004, Pages 73-78

  Komorowska Timek, Ewa ^a,b   Timek, Tomasz A ^b   Brevetti, Lucy S ^a   Szuba, Andrzej ^a   Stuehlinger, Marcus ^a   Hardesty, Robert A ^b   Buncke, Harry J ^a  

^a Buncke Clinic   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; EPIGASTRIC SKIN FLAP; HEMOPERFUSION; NONHUMAN; PEDICLED SKIN FLAP; PRIORITY JOURNAL; RAT; SKIN FLAP; SKIN NECROSIS; SKIN PERFUSION; TISSUE NECROSIS;

ADMINISTRATION, ORAL; ANIMALS; ARGININE; RATS; RATS, SPRAGUE-DAWLEY; SURGICAL FLAPS; VASODILATOR AGENTS;

EID: 3042839161     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sap.0000106582.91877.02     Document Type: Article

References (28)

1. Wennmalm A. Endothelial nitric oxide and cardiovascular disease. J Intern Med. 1994;235:317-327.
2. Murohara T, Asahara T, Silver M, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101: 2567-2578.
3. Um SC, Suzuki S, Toyokuni S, et al. Involvement of nitric oxide in survival of random pattern skin flap. Plast Reconstr Surg. 1998;101: 785-792.
4. Erçöçen AR, Apaydin I, Emiroǧlu M, et al. The effects of L-arginine and iloprost on the viability of random skin flaps in rats. Scand J Plast Reconstr Hand Surg. 1998;32:19-25.
5. Brown AA, Hu FB. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr. 2001;73:673-686.
6. Bode-Böger SM, Böger RH, Alfke H, et al. L-arginine induces nitric oxide-dependent vasodilatation in patients with critical limb ischemia: a randomized, controlled study. Circulation. 1996;93:85-90.
7. Creager MA. Medical management of peripheral arterial disease. Cardiol Rev. 2001;9:238-245.
8. Hiatt WR. New treatment options in intermittent claudication: the US experience. Int J Clin Pract Suppl. 2001;119:20-27.
9. Lerman A, Suwaidi JA, Velianou JL. L-arginine: a novel therapy for coronary disease? Expert Opin Invest Drugs. 1999;8:1785-1793.
10. Cheng JW, Balwin SN. L-arginine in the management of cardiovascular diseases. Ann Pharmacother. 2001;35:755-764.
11. Cordeiro PG, Mastorakos DP, Hu QY, et al. The protective effect of L-arginine on ischemia-reperfusion injury in rat skin flaps. Plast Reconstr Surg. 1997;100:1227-1233.
12. Knox LK, Angel M. F, Gamper T, et al. Secondary ischemic tolerance improved by administration of L-NAME in rat flaps. Microsurgery. 1996;17:425-427.
13. Cordeiro PG, Santamaria E, Hu QY. Use of a nitric oxide precursor to protect pig myocutaneous flaps from ischemia-reperfusion injury. Plast Reconstr Surg. 1998;102:2040-2051.
14. Oshima H. The influence of skin flap ischemia on serum nitric oxide concentrations. Microsurgery. 1996;17:191-197.
15. Padubidri AN, Browne E. Modification of flap design of the epigastric artery flap in rats: a new experimental flap model. Ann Plast Surg. 1997;39:500-504.
16. Padubidri A, Browne E. Effect of vascular endothelial growth factor (VEGF) on survival of random extension of axial pattern skin flaps in the rat. Ann Plast Surg. 1996;37:604-611.
17. Komorowska-Timek E, Newlin L, Zhang F, et al. Shortening of rat teeth prevents autocannibalization of surgical flaps. J Reconstr Microsurg. 1999;15:303-306.
18. Deveci D, Egginton S. Development of the fluoresvcent microsphere rechnique for quantifying regional blood flow in small mammals. Exp Physiol. 1999;84:615-630.
19. Böger RH, Bode-Böger SM, Szuba A, et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 1998;98:1842-1847.
20. Lovett JE, Fink BF, Bernard A, et al. Analysis of nitric oxide activity in prevention of reperfusion injury. Ann Plast Surg. 2001;46:269-274.
21. Gribbe O, Lundeberg T, Samuelson UE, et al. Nitric oxide activity and endothelial ultrastructure in ischaemic skin-flaps. Br J Plast Surg. 1997;50:483-490.
22. Knox LK, Stewart AG, Hayward PG, et al. Nitric oxide synthase inhibitors improve skin flap survival in the rat. Microsurgery. 1994;15: 708-711.
23. Phan LH, Hickey MJ, Niazi ZB, et al. Nitric oxide synthase inhibitor, nitro-iminoethyl-L-omithine, reduces ischemia-reperfusion injury in rabbit. Microsurgery. 1994;15:703-707.
24. Sasaki G, Pang CY. Hemodynamics and viability of acute neurovascular island skin flap in rats. Plast Reconstr Surg. 1980;65:152-158.
25. Tsur H, Daniller A, Strauch B. Neovascularization of skin flaps: route and timing. Plast Reconstr Surg. 1980;66:85-90.
26. Henry TD. Therapeutic angiogenesis. BMJ. 1999;318:1536-1539.
27. Hamon M, Vallet B, Bauters C, et al. Long-term administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. Circulation. 1994;90:1357-1362.
28. Maxwell AJ, Cooke JP. Cardiovascular effects of L-arginine. Curr Opin Nephrol Hypertens. 1998;7:63-70.